Back to Search
MELINDA MORTENSON, M.D.
M.D.
Surgical Oncology Physician
NPI: 1447231931IndividualAccepts Medicare
Specialties, Licenses & Credentials
Surgical Oncology PhysicianPrimary
Surgery — Surgical Oncology
Code: 2086X0206X
A75028(CA)
CMS Specialties
PrimaryGENERAL SURGERY
Education
UNIVERSITY OF CALIFORNIA, DAVIS SCHOOL OF MEDICINE
Class of 1999
Research & Publications (15)
BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer.
PMID 17960583·J Cell Biochem·2007
8-other
Total mesorectal excision and pelvic node dissection for rectal cancer: an appraisal.
PMID 17336243·Surg Oncol Clin N Am·2007
6-review
An analysis of cost and clinical outcome in palliation for advanced pancreatic cancer.
PMID 16105527·Am J Surg·2005
8-other
Reduction in BCL-2 levels by 26S proteasome inhibition with bortezomib is associated with induction of apoptosis in small cell lung cancer.
PMID 16022909·Lung Cancer·2005
8-other
Immediate breast reconstruction after mastectomy increases wound complications: however, initiation of adjuvant chemotherapy is not delayed.
PMID 15381618·Arch Surg·2004
8-other
Effects of the proteasome inhibitor bortezomib alone and in combination with chemotherapy in the A549 non-small-cell lung cancer cell line.
PMID 15197486·Cancer Chemother Pharmacol·2004
7-preclinical
Symptomatic pancreatic polypeptide-secreting tumor of the distal pancreas (PPoma).
PMID 12794252·Int J Gastrointest Cancer·2002
5-case
Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: a randomized controlled trial (NCT00506311).
PMID 18564433·World J Surg Oncol·2008
2-rct
Parathyroid exploration in the reoperative neck: improved preoperative localization with 4D-computed tomography.
PMID 18471717·J Am Coll Surg·2008
8-other
ERK/BCL-2 pathway in the resistance of pancreatic cancer to anoikis.
PMID 19062038·J Surg Res·2009
8-other
Diagnosis and management of cystic neoplasms of the pancreas: an evidence-based approach.
PMID 18589369·J Am Coll Surg·2008
6-review
Comparison of two methods of future liver remnant volume measurement.
PMID 17924174·J Gastrointest Surg·2008
4-observational
Targeting BCL-2 overexpression in various human malignancies through NF-kappaB inhibition by the proteasome inhibitor bortezomib.
PMID 15791457·Cancer Chemother Pharmacol·2005
8-other
Proteasome inhibition with PS-341 (bortezomib) in lung cancer therapy.
PMID 14981579·Semin Oncol·2004
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2025 MORSE AVE
SACRAMENTO, CA 95825 - Phone
- (916) 973-5649
Quick Facts
- NPI
- 1447231931
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 15
Are you this provider?
Claim Your Profile